Cutaneous and Systemic Mastocytosis in Children: A Risk Factor for Anaphylaxis?

被引:0
|
作者
A. Matito
M. Carter
机构
[1] Spanish Network on Mastocytosis (REMA),Instituto de Estudios de Mastocitosis de Castilla
[2] National Institute of Health (NIH),La Mancha, Hospital Virgen del Valle
来源
关键词
Anaphylaxis; Mastocytosis; Pediatric;
D O I
暂无
中图分类号
学科分类号
摘要
Childhood mastocytosis is usually a clonal mast cell disease related to activating mutations in KIT. The symptoms in childhood mastocytosis are typically cutaneous in nature although systemic symptoms including anaphylaxis due to the release of mast cells (MC) mediators can also manifest. The prevalence of anaphylaxis reported in childhood mastocytosis is higher than the rates reported in the pediatric general population, but lower than the prevalence of anaphylaxis described in adult mastocytosis. An extensive cutaneous involvement was reported as a risk factor for anaphylaxis, and patients with diffuse cutaneous mastocytosis have been documented to have more severe anaphylaxis symptoms. Anaphylaxis due to unknown causes or idiopathic anaphylaxis was the primary etiology in pediatric mastocytosis, followed by foods as the most relevant identified trigger; however, hymenoptera stings are not a frequent trigger of anaphylaxis in children with mastocytosis in contrast to the adult patients.
引用
收藏
相关论文
共 50 条
  • [21] Neurocognitive dysfunction and anaphylaxis in pediatric maculopapular cutaneous mastocytosis
    Gurnee, Emily A.
    Phung, Thuy L.
    Guo, Emily
    Fong, Aaron
    Tollefson, Megha
    Henry Nguyen
    Brandling-Bennett, Heather A.
    Moriarty, Natalie
    Paller, Amy S.
    Huynh, Thy
    Lawley, Leslie P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (01): : 409 - 410
  • [22] Risk factors for anaphylaxis in patients with mastocytosis
    Gorska, Aleksandra
    Niedoszytko, Marek
    Lange, Magdalena
    Chelminska, Marta
    Nedoszytko, Boguslaw
    Wasag, Bartosz
    Slominski, Jan Marek
    Gruchala-Niedoszytko, Marta
    Nowicki, Roman
    Jassem, Ewa
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (1-2): : 46 - 53
  • [23] CONGENITAL DIFFUSE CUTANEOUS AND SYSTEMIC MASTOCYTOSIS
    LABEILLE, B
    KREMP, O
    LOK, C
    TEILLAC, D
    RISBOURG, B
    DENOEUX, JP
    DEPROST, Y
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1990, 117 (11): : 805 - 806
  • [24] Bullous Mastocytosis; Cutaneous or Systemic Disease?
    Kinneman, Lauren
    Molloy, Barbara
    Silverman, Robert
    Johal, Jasbir
    Mensah-Bonsu, Noel
    Alpan, Oral
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB216 - AB216
  • [25] SYSTEMIC MASTOCYTOSIS WITHOUT CUTANEOUS INVOLVEMENT
    KATSUDA, S
    OKADA, Y
    ODA, Y
    TANIMOTO, K
    TAKABATAKE, S
    ACTA PATHOLOGICA JAPONICA, 1987, 37 (01): : 167 - 177
  • [26] MANAGEMENT OF CUTANEOUS MASTOCYTOSIS WITH SYSTEMIC TACROLIMUS
    Curtiss, M. L.
    Hopper, S. P.
    Atkinson, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A78 - A79
  • [27] BULLOUS CUTANEOUS MASTOCYTOSIS WITH SYSTEMIC MANIFESTATIONS
    AGACHE, P
    LAURENT, R
    BIDARDDE.AM
    CAPERAN, D
    BULLETIN DE LA SOCIETE FRANCAISE DE DERMATOLOGIE ET DE SYPHILIGRAPHIE, 1973, 80 (05): : 506 - 507
  • [28] An Indolent Cause of Recurrent Anaphylaxis with NSAIDs: Systemic Mastocytosis
    Aytekin, Gokhan
    Findik, Siddika
    Colkesen, Fatih
    Yildiz, Eray
    Caliskaner, Ahmet Zafer
    ASTIM ALLERJI IMMUNOLOJI, 2019, 17 (03): : 169 - 171
  • [29] DECREASED FREQUENCY AND INTENSITY OF ANAPHYLAXIS IN SYSTEMIC MASTOCYTOSIS WITH OMALIZUMAB
    Karpinska-Leydier, K.
    Bell, A.
    Maddineni, G.
    Mena, L. Veras
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S96 - S96
  • [30] Plasma soluble KIT levels in mastocytosis and in systemic anaphylaxis
    Akin, C
    Schwartz, LB
    Kitoh, T
    Obayashi, H
    Worobec, AS
    Semere, T
    Scott, LM
    Metcalfe, DD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S274 - S274